Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avinger Inc

AVGR
Current price
0.47 USD 0 USD (0.00%)
Last closed 0.47 USD
ISIN US0537348858
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 1 524 868 USD
Yield for 12 month -83.66 %
1Y
3Y
5Y
10Y
15Y
AVGR
21.11.2021 - 28.11.2021

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California. Address: 400 Chesapeake Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.00 USD

P/E ratio

Dividend Yield

Current Year

+7 652 000 USD

Last Year

+8 273 000 USD

Current Quarter

+1 650 000 USD

Last Quarter

+1 847 000 USD

Current Year

+2 003 000 USD

Last Year

+2 654 000 USD

Current Quarter

+426 000 USD

Last Quarter

+378 000 USD

Key Figures AVGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 546 000 USD
Operating Margin TTM -223.44 %
Price to Earnings
Return On Assets TTM -65.22 %
PEG Ratio
Return On Equity TTM -3 332.59 %
Wall Street Target Price 5.00 USD
Revenue TTM 7 429 000 USD
Book Value -4.85 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -9.50 %
Dividend Yield
Gross Profit TTM 2 654 000 USD
Earnings per share -8.76 USD
Diluted Eps TTM -8.76 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -260.86 %

Dividend Analytics AVGR

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History AVGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio
Last Split Date 13.09.2023

Stock Valuation AVGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.17
Price Sales TTM 0.21
Enterprise Value EBITDA -0.40
Price Book MRQ 0.39

Financials AVGR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVGR

For 52 weeks

0.39 USD 5.45 USD
50 Day MA 0.84 USD
Shares Short Prior Month 65 036
200 Day MA 1.91 USD
Short Ratio 0.22
Shares Short 63 133
Short Percent 6.10 %